Inspire Veterinary Partners, Inc.

Inspire Veterinary Partners, Inc.

IVP
Inspire Veterinary Partners, Inc.US flagNASDAQ Capital Market
0.03
USD
+0.03
- -
85,826.00Market Cap
2021 Y
2022 Y
2023 Y
2024 Y
TTM
Revenue per Share
927.63
3,578.89
9,678.12
74.73
66.01
Basic EPS, GAAP
-484.37
-1,787.45
-8,742.97
-65.24
-50.67
Free Cash Flow per Basic Share
-844.42
-1,031.7
-2,440.22
-46.14
-18.42
Dividend per Share
- -
- -
- -
- -
- -
Book Value per Share
-484.35
-2,271.8
-12,312.75
-163.71
-188.05
Tangible Book Value per Share
-989.49
-5,633.05
-6,644.76
-36.45
-25.86
Basic Weighted Avg Shares
- -
- -
- -
- -
- -
Sales/Revenue/Turnover
3
10
17
17
16
Operating Margin (%)
-41.08
-35.77
-43.03
-56.88
-57.63
Depreciation Expense
- -
1
1
2
1
Net Income, GAAP
-1
-5
-15
-14
-12
Effective Tax Rate (%)
- -
- -
- -
- -
- -
Profit Margin (%)
-52.22
-49.94
-88.71
-85.97
-76.75
Working Capital
- -
-6
-6
-6
-6
LT Debt
5
18
15
10
10
Total Equity
-1
-5
-1
2
4
Return on Invested Capital (%)
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
Return on Common Equity (%)
- -
- -
- -
- -
- -

Capital Structure

FRC

in mil. unless spec.
Mar'25
Jun'25
Sep'25
ST Debt
5
7
7
LT Borrowings
8
8
8
LT Finance Leases
2
2
2
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
2
2
4
Market Capitalization
- -
- -
- -

Working Capital

FRC

in mil. unless spec.
Mar'25
Jun'25
Sep'25
Total Current Assets
3
1
4
Cash, Cash Equivalents & STI
2
- -
3
Accounts Receivable, Net
- -
- -
- -
Inventories
- -
- -
- -
Total Current Liabilities
7
10
10
Payables & Accruals
2
3
3
ST Debt
5
7
7
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
- -
-298.16%
Free Cash Flow
- -
- -
143.64%
Net Income, GAAP
- -
- -
-3.57%
Sales/Revenue/Turnover
- -
- -
-0.5%
Total Cash Common Dividend
- -
- -
-18.58%

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
4
4
4
4
17
2024
5
4
4
3
17
2025
4
4
4
- -
- -

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
-560.03
-26.84
-196.72
- -
-8,742.97
2024
-233.44
-17.59
-21.21
- -
-65.24
2025
-10.87
-12.58
-10.37
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
- -
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -

Company Description

APIChat
CEO
Morgan Wood
Full Time Employees
113
Sector
Consumer Cyclical
Industry
Personal Products & Services
Address
780 Lynnhaven Parkway Virginia Beach VA United States of America 23452
IPO Date
Aug 30, 2023
Business
Inspire Veterinary Partners, Inc. owns and operates a network of veterinary hospitals throughout the United States, specializing primarily in small animal general practice with an emphasis on canine and feline care. The company’s core services include preventive care such as annual health exams, parasite control, dental health, nutrition and body condition counseling, neurological evaluations, radiology, bloodwork, and breed-specific preventive care. Surgical services encompass soft tissue procedures including spays and neuters, mass removals, splenectomies, gastropexies, and orthopedic surgeries. Additional offerings at select locations include mixed animal care, critical care, specialty services, acupuncture, chiropractic treatments, and wellness programs. The company also recently expanded into equine care and emergency services at one location. Founded in 2020 and headquartered in Virginia Beach, Virginia, Inspire Veterinary Partners operates 13 veterinary hospitals across nine U.S. states. The company targets companion animal owners seeking comprehensive veterinary services through its employee-owned model. Inspire Veterinary Partners pursues growth through acquisitions of existing hospitals that show strong financial performance and market potential, with no limitation to geographic regions as evidenced by recent acquisitions in the Northeast. Recent major developments include a strategic focus on expanding the hospital network and service offerings, highlighted by the addition of equine care and emergency services since 2022. The company completed a Nasdaq IPO in 2023 to support its expansion and has since engaged in financing activities including a $6.0 million registered direct offering to strengthen its balance sheet. Operationally, Inspire Veterinary Partners implemented a 1-for-25 reverse stock split in 2024 to enhance trading liquidity. The company also launched an online pet pharmacy leveraging industry relationships to distribute prescription and over-the-counter veterinary products. Inspire Veterinary Partners maintains a distributed leadership and support structure across the United States, supporting its geographically diverse portfolio. The company’s emphasis on comprehensive, high-quality veterinary care combined with expansion through acquisitions positions it as a growing player in the U.S. veterinary hospital industry. As of 2025, Inspire Veterinary Partners continues to focus on increasing clinic revenues and new client growth while improving operational efficiencies. In summary, Inspire Veterinary Partners provides multiservice veterinary hospital care focused on small animals with recent expansions into mixed animal and equine services, supported by strategic acquisitions, capital market activities, and service innovation to drive growth across multiple U.S. states.

Company News

APIChat
  • Inspire Veterinary Partners (NASDAQ:IVP) and Yunhong Green CTI (NASDAQ:YHGJ) Financial Comparison

  • Inspire Veterinary Partners (IVP) Stock Jumps 31% After-Hours — Here's What You Should Know

  • Inspire Veterinary Partners (NASDAQ:IVP) & TAAT Global Alternatives (OTCMKTS:TOBAF) Head-To-Head Survey

  • What Fueled Inspire Veterinary Partners' (IVP) 27% After-Hours Rally?

  • Contrasting Purple Innovation (NASDAQ:PRPL) and Inspire Veterinary Partners (NASDAQ:IVP)

  • Zacks Initiates Coverage of Inspire Veterinary With Underperform Recommendation

  • Inspire Veterinary Partners Announces Third Quarter 2025 Financial Results

  • Inspire Veterinary Partners Announces Online Pet Pharmacy

  • Inspire Veterinary Partners Provides Shareholder Update

  • Inspire Veterinary Partners to Present at the H.C. Wainwright 27th Annual Global Investment Conference

  • Inspire Veterinary Partners Regains Compliance with Nasdaq Listing Requirements

  • Inspire Veterinary Partners Reports Second Quarter 2025 Financial Results

  • Inspire Veterinary Partners Signs Exclusive, Non-Binding Letter of Intent to Acquire New Jersey Animal Hospital

  • Inspire Veterinary Partners Announces up to $10M in Financing at $1.00 per Share Through Cash and Transferred Securities

  • Inspire Veterinary Partners Launches Company-Wide Incentive Program

  • Inspire Veterinary Partners Announces AI Integration into Practice Management Software in Partnership with Leading Software Provider Covetrus

  • Inspire Veterinary Partners Acquires Central Florida Animal Hospital

  • Inspire Veterinary Partners Reports First Quarter 2025 Financial Results

  • Inspire Veterinary Partners Announces Participation in the D. Boral Capital Inaugural Global Conference

  • Inspire Veterinary Partners Celebrates Record Veterinary Hiring and the Appointment of Lynley Kees to Chief People Officer